ABBOTT INDIA LIMITED (ABBOTINDIA) financials

ABBOTT INDIA LIMITED (ABBOTINDIA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.[1]It was established in 1944.[2]

Market Cap: ₹55,877Cr.
Current Price: ₹26,295
Stock P/E: 34.6
ROE: 34.4%
ROCE: 44.8%
Book Value: ₹2,247
Dividend Yield: 2.00%
52W High / Low: ₹30,655/25,135

In Jun 2026, ABBOTT INDIA LIMITED (ABBOTINDIA) reported sales ₹1,814 Cr and net profit ₹429 Cr.

Annual TTM: sales ₹7,004 Cr, net profit ₹1,615 Cr.

Shareholding: Promoters 74.99% (Sep 2026), FIIs 0.40% (Sep 2026), DIIs 8.99% (Sep 2026), Public 15.62% (Sep 2026), No. of Shareholders 75,769% (Sep 2026).

ABBOTINDIA quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	1,633	1,614	1,605	1,738	1,757	1,724	1,710	1,814
Expenses	1,194	1,178	1,176	1,293	1,255	1,261	1,229	1,291
Operating Profit	439	436	429	446	502	463	481	522
OPM %	27%	27%	27%	26%	29%	27%	28%	29%
Other Income	60	72	76	73	70	70	76	75
Interest	2	2	4	6	8	5	6	6
Depreciation	18	18	18	19	19	19	19	20
Profit before tax	479	488	483	493	546	509	531	572
Tax %	25%	26%	24%	26%	24%	26%	26%	25%
Net Profit	359	361	367	366	415	376	395	429
EPS in Rs	168.76	169.78	172.73	172.18	195.43	176.93	185.86	201.66
Raw PDF	—	—	—	—	—	—	—	—

ABBOTINDIA profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	4,093	4,310	4,919	5,349	5,849	6,409	6,929	7,004
Expenses	3,336	3,388	3,832	4,143	4,396	4,714	5,037	5,035
Operating Profit	757	922	1,088	1,206	1,453	1,695	1,892	1,969
OPM %	18%	21%	22%	23%	25%	26%	27%	28%
Other Income	114	81	77	154	248	275	288	291
Interest	9	18	19	16	12	11	25	25
Depreciation	60	58	66	70	71	72	76	76
Profit before tax	803	926	1,080	1,274	1,618	1,887	2,079	2,158
Tax %	26%	25%	26%	25%	26%	25%	25%	—
Net Profit	593	691	799	949	1,201	1,414	1,552	1,615
EPS in Rs	279.04	325.04	375.87	446.80	565.30	665.64	730.39	759.88
Dividend Payout %	90%	85%	73%	73%	73%	71%	90%	—

ABBOTINDIA balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	21	21	21	21	21	21	21	21
Reserves	1,987	2,410	2,581	2,799	3,167	3,678	4,212	4,753
Borrowings	0	175	153	152	113	83	197	172
Other Liabilities	932	940	1,086	1,253	1,254	1,411	1,487	1,556
Total Liabilities	2,941	3,547	3,840	4,224	4,556	5,193	5,917	6,502
Fixed Assets	105	270	251	271	237	225	336	331
CWIP	1	2	1	1	4	10	18	6
Investments	0	0	0	0	0	0	0	0
Other Assets	2,835	3,275	3,589	3,952	4,315	4,958	5,563	6,165
Total Assets	2,941	3,547	3,840	4,224	4,556	5,193	5,917	6,502

ABBOTINDIA cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	499	626	727	948	893	1,213	1,012	1,319
Cash from Investing Activity	-257	-401	-72	-396	-148	-416	182	-371
Cash from Financing Activity	-143	-217	-582	-637	-639	-745	-925	-1,066
Net Cash Flow	99	8	73	-86	107	52	269	-118
Free Cash Flow	504	611	704	904	860	1,165	960	1,307
CFO/OP	125%	113%	104%	114%	102%	111%	86%	98%

ABBOTINDIA shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%
FIIs	0.17%	0.16%	0.16%	0.16%	0.19%	0.27%	0.38%	0.40%
DIIs	9.01%	8.91%	9.18%	9.11%	9.00%	8.93%	8.77%	8.99%
Public	15.85%	15.94%	15.67%	15.74%	15.83%	15.81%	15.85%	15.62%
No. of Shareholders	67,892	69,934	67,584	71,199	75,801	75,866	78,320	75,769

ABBOTINDIA key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	27	28	21	21	22	20	22	19
Inventory Days	106	83	110	94	80	70	92	94
Days Payable	116	104	116	122	109	114	110	109
Cash Conversion Cycle	17	8	14	-6	-8	-24	3	3
Working Capital Days	22	10	4	-7	-8	-14	99	2
ROCE %	37%	35%	35%	38%	41%	46%	46%	45%

ABBOTINDIAUpdated 15 Oct 2026, 5:00

Abbott India Limited

ABBOTINDIAUpdated 15 Oct 2026, 5:00

Market Cap

₹55,877Cr.

Current Price

₹26,295

High / Low

₹30,655/25,135

Stock P/E

34.6

ROE34.4%

ROCE44.8%

Book Value₹2,247

Face Value₹10.0

Dividend Yield2.00%

About

Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.[1]It was established in 1944.[2]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	1479	3	1124	56	17	390	26	290	136.59
Sep 2023	1494	3	1113	56	18	415	25	313	147.27
Dec 2023	1437	3	1049	56	18	422	26	311	146.35
Mar 2024	1439	3	1109	81	18	390	26	287	135.09
Jun 2024	1558	3	1167	67	18	437	25	328	154.36
Sep 2024	1633	2	1194	60	18	479	25	359	168.76
Dec 2024	1614	2	1178	72	18	488	26	361	169.78
Mar 2025	1605	4	1176	76	18	483	24	367	172.73
Jun 2025	1738	6	1293	73	19	493	26	366	172.18
Sep 2025	1757	8	1255	70	19	546	24	415	195.43
Dec 2025	1724	5	1261	70	19	509	26	376	176.93
Mar 2026	1710	6	1229	76	19	531	26	395	185.86
Jun 2026	1814	6	1291	75	20	572	25	429	201.66

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	2289	0	1977	48	15	344	34	229	107.75
Mar 2016	2614	3	2250	50	14	398	36	255	120.12
Mar 2017	2903	2	2505	57	16	436	37	277	130.19
Mar 2018	3298	4	2774	117	16	621	35	401	188.82
Mar 2019	3679	2	3074	113	17	699	36	450	211.93
Mar 2020	4093	9	3336	114	60	803	26	593	279.04
Mar 2021	4310	18	3388	81	58	926	25	691	325.04
Mar 2022	4919	19	3832	77	66	1080	26	799	375.87
Mar 2023	5349	16	4143	154	70	1274	25	949	446.8
Mar 2024	5849	12	4396	248	71	1618	26	1201	565.3
Mar 2025	6409	11	4714	275	72	1887	25	1414	665.64
Mar 2026	6929	25	5037	288	76	2079	25	1552	730.39
TTM	7004	25	5035	291	76	2158	—	1615	759.88

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	74.99%
FIIs	0.4%
DIIs	8.99%
Public	15.62%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	74.99%	0.18%	8.73%	16.09%
Mar 2024	74.99%	0.18%	8.91%	15.92%
Jun 2024	74.99%	0.18%	8.81%	16.01%
Sep 2024	74.99%	0.17%	9%	15.86%
Dec 2024	74.99%	0.17%	9.01%	15.85%
Mar 2025	74.99%	0.16%	8.91%	15.94%
Jun 2025	74.99%	0.16%	9.18%	15.67%
Sep 2025	74.99%	0.16%	9.11%	15.74%
Dec 2025	74.99%	0.19%	9%	15.83%
Mar 2026	74.99%	0.27%	8.93%	15.81%
Jun 2026	74.99%	0.38%	8.77%	15.85%
Sep 2026	74.99%	0.4%	8.99%	15.62%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Other Assets	Total Assets
Mar 2015	21	916	0	436	1374	96	4	1274	1374
Mar 2016	21	1174	0	421	1616	108	3	1505	1616
Mar 2017	21	1366	0	679	2066	110	6	1950	2066
Mar 2018	21	1672	0	723	2416	81	2	2333	2416
Mar 2019	21	1987	0	932	2941	105	1	2835	2941
Mar 2020	21	2410	175	940	3547	270	2	3275	3547
Mar 2021	21	2581	153	1086	3840	251	1	3589	3840
Mar 2022	21	2799	152	1253	4224	271	1	3952	4224
Mar 2023	21	3167	113	1254	4556	237	4	4315	4556
Mar 2024	21	3678	83	1411	5193	225	10	4958	5193
Mar 2025	21	4212	197	1487	5917	336	18	5563	5917
Mar 2026	21	4753	172	1556	6502	331	6	6165	6502

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	215	-187	-58	-30
Mar 2016	249	-77	-80	91
Mar 2017	307	-155	-90	62
Mar 2018	153	-215	-102	-165
Mar 2019	499	-257	-143	99
Mar 2020	626	-401	-217	8
Mar 2021	727	-72	-582	73
Mar 2022	948	-396	-637	-86
Mar 2023	893	-148	-639	107
Mar 2024	1213	-416	-745	52
Mar 2025	1012	182	-925	269
Mar 2026	1319	-371	-1066	-118

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	21	20	22	29	27	28	21	21	22	20	22	19
Inventory Days	107	91	107	112	106	83	110	94	80	70	92	94
Days Payable	54	56	101	92	116	104	116	122	109	114	110	109
Cash Conversion Cycle	74	54	28	49	17	8	14	-6	-8	-24	3	3
Working Capital Days	30	32	21	63	22	10	4	-7	-8	-14	99	2
ROCE %	40%	38%	34%	41%	37%	35%	35%	38%	41%	46%	46%	45%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ABBOTT INDIA LIMITED (ABBOTINDIA)?

The reported market capitalisation for ABBOTT INDIA LIMITED (ABBOTINDIA) is ₹55,877Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of ABBOTINDIA?

The current price shown for ABBOTT INDIA LIMITED (ABBOTINDIA) on Fincrux is ₹26,295 with a 52-week high/low of ₹30,655/25,135.

What is the P/E ratio of ABBOTT INDIA LIMITED (ABBOTINDIA)?

The stock P/E for ABBOTT INDIA LIMITED (ABBOTINDIA) is 34.6 on Fincrux, with ROE at 34.4% and ROCE at 44.8%.

What were ABBOTINDIA latest quarterly results?

For Jun 2026, ABBOTT INDIA LIMITED (ABBOTINDIA) reported sales ₹1,814 Cr and net profit ₹429 Cr (figures in ₹ crore unless noted).

What are ABBOTINDIA annual sales and net profit?

For TTM, ABBOTT INDIA LIMITED (ABBOTINDIA) shows sales of ₹7,004 Cr and net profit of ₹1,615 Cr on the Fincrux profit & loss statement.

Who owns ABBOTT INDIA LIMITED (ABBOTINDIA)?

Latest shareholding for ABBOTT INDIA LIMITED (ABBOTINDIA) on Fincrux: Promoters 74.99% (Sep 2026), FIIs 0.40% (Sep 2026), DIIs 8.99% (Sep 2026), Public 15.62% (Sep 2026), No. of Shareholders 75,769% (Sep 2026).

Where can I find ABBOTT INDIA LIMITED (ABBOTINDIA) financials?

ABBOTT INDIA LIMITED (ABBOTINDIA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show ABBOTINDIA balance sheet and cash flow?

Yes. The ABBOTT INDIA LIMITED (ABBOTINDIA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 15 October 2026 at 5:00